Analyst Ratings For AC Immune SA (NASDAQ:ACIU)
Today, AC Immune SA (NASDAQ:ACIU) stock was downgraded by UBS Group from Buy to Neutral.
There are 2 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on AC Immune SA (NASDAQ:ACIU) is Buy with a consensus target price of $16.50 per share, a potential 300.49% upside.
Some recent analyst ratings include
- 2/1/2019-AC Immune SA (NASDAQ:ACIU) gets downgraded to Neutral by UBS Group
- 1/24/2019-AC Immune SA (NASDAQ:ACIU) had its Buy rating reiterated by HC Wainwright with a $18.00 price target
- 11/12/2018-AC Immune SA (NASDAQ:ACIU) has coverage initiated with a Outperform rating and $18.00 price target
Recent Trading Activity for AC Immune SA (NASDAQ:ACIU)
Shares of AC Immune SA closed the previous trading session at 4,12 +0,47 12,88 % with 4.15 shares trading hands.
